Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131358) titled 'Machine Learning-Based Modeling for Optimal Anticoagulation Initiation Timing and Individualized Hemorrhagic Risk Assessment in Patients with Cerebral Hemorrhage' on Sept. 1.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Huashan Hospital, Fudan University
Condition:
Cerebral hemorrhage accompanied by deep vein thrombosis or pulmonary embolism
Intervention:
Verification cohort:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-09-01
Target Sample Size: Verification cohort:1200;Model development cohort:2000;
Countries of Recruitment:
Chin...